世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Dydrogesterone Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dydrogesterone Drug was estimated to be worth US$ 828 million in 2024 and is forecast to a readjusted size of US$ 1093 million by 2031 with a CAGR of 4.0% during the forecast ... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Dydrogesterone Drug was estimated to be worth US$ 828 million in 2024 and is forecast to a readjusted size of US$ 1093 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.Dydrogesterone is a synthetic progestogen that mimics the action of natural progesterone. It is primarily used to treat conditions related to progesterone deficiency, such as menstrual disorders, endometriosis, threatened or recurrent miscarriage, and hormone replacement therapy (HRT) in menopausal women. Unlike other progestins, dydrogesterone has minimal androgenic or estrogenic effects, making it well-tolerated with fewer side effects. It is often prescribed as an oral medication and plays a vital role in maintaining pregnancy and regulating the menstrual cycle. Market Driver: The dydrogesterone drug market is driven by the increasing prevalence of gynecological disorders such as endometriosis, menstrual irregularities, and recurrent miscarriages. As more women seek effective hormone therapy solutions, the demand for dydrogesterone continues to rise, particularly due to its better tolerability and lower androgenic side effects compared to other progestins. Additionally, the growing awareness about fertility treatments and assisted reproductive technologies (ART) has further fueled the market, as dydrogesterone is widely used to support pregnancy in cases of progesterone deficiency. Market Challenge: Despite its benefits, the dydrogesterone market faces challenges such as competition from alternative progestins and natural progesterone formulations. Some healthcare providers prefer bioidentical progesterone over synthetic alternatives due to concerns about long-term safety. Additionally, stringent regulatory requirements and the high cost of drug development pose barriers to market expansion. Patent expirations and the entry of generic alternatives also create pricing pressure, affecting the profitability of branded dydrogesterone products. Global key players of Dydrogesterone Drug include Abbott, Viatris, etc. The top two players hold a share of 70%. Asia-Pacific is the largest market, with a share of 68%, followed by Europe and South America, with share 15% and 9%, separately. In terms of product type, Dydrogesterone is the largest segment, occupied for 75%. And in terms of application, Infertility has a share of 67%. This report aims to provide a comprehensive presentation of the global market for Dydrogesterone Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dydrogesterone Drug by region & country, by Type, and by Application. The Dydrogesterone Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dydrogesterone Drug. Market Segmentation By Company Abbott Viatris Mankind Pharma Zydus Cadila Healthcare Segment by Type Dydrogesterone Dydrogesterone+Estradiol Compound Segment by Application Infertility Gynecological Diseases Threatened Abortion Other By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Dydrogesterone Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Sales, revenue of Dydrogesterone Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Sales, revenue of Dydrogesterone Drug in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Dydrogesterone Drug Product Introduction 1.2 Global Dydrogesterone Drug Market Size Forecast 1.2.1 Global Dydrogesterone Drug Sales Value (2020-2031) 1.2.2 Global Dydrogesterone Drug Sales Volume (2020-2031) 1.2.3 Global Dydrogesterone Drug Sales Price (2020-2031) 1.3 Dydrogesterone Drug Market Trends & Drivers 1.3.1 Dydrogesterone Drug Industry Trends 1.3.2 Dydrogesterone Drug Market Drivers & Opportunity 1.3.3 Dydrogesterone Drug Market Challenges 1.3.4 Dydrogesterone Drug Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Dydrogesterone Drug Players Revenue Ranking (2024) 2.2 Global Dydrogesterone Drug Revenue by Company (2020-2025) 2.3 Global Dydrogesterone Drug Players Sales Volume Ranking (2024) 2.4 Global Dydrogesterone Drug Sales Volume by Company Players (2020-2025) 2.5 Global Dydrogesterone Drug Average Price by Company (2020-2025) 2.6 Key Manufacturers Dydrogesterone Drug Manufacturing Base and Headquarters 2.7 Key Manufacturers Dydrogesterone Drug Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Dydrogesterone Drug 2.9 Dydrogesterone Drug Market Competitive Analysis 2.9.1 Dydrogesterone Drug Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Dydrogesterone Drug Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dydrogesterone Drug as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Dydrogesterone 3.1.2 Dydrogesterone+Estradiol Compound 3.2 Global Dydrogesterone Drug Sales Value by Type 3.2.1 Global Dydrogesterone Drug Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Dydrogesterone Drug Sales Value, by Type (2020-2031) 3.2.3 Global Dydrogesterone Drug Sales Value, by Type (%) (2020-2031) 3.3 Global Dydrogesterone Drug Sales Volume by Type 3.3.1 Global Dydrogesterone Drug Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Dydrogesterone Drug Sales Volume, by Type (2020-2031) 3.3.3 Global Dydrogesterone Drug Sales Volume, by Type (%) (2020-2031) 3.4 Global Dydrogesterone Drug Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Infertility 4.1.2 Gynecological Diseases 4.1.3 Threatened Abortion 4.1.4 Other 4.2 Global Dydrogesterone Drug Sales Value by Application 4.2.1 Global Dydrogesterone Drug Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Dydrogesterone Drug Sales Value, by Application (2020-2031) 4.2.3 Global Dydrogesterone Drug Sales Value, by Application (%) (2020-2031) 4.3 Global Dydrogesterone Drug Sales Volume by Application 4.3.1 Global Dydrogesterone Drug Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Dydrogesterone Drug Sales Volume, by Application (2020-2031) 4.3.3 Global Dydrogesterone Drug Sales Volume, by Application (%) (2020-2031) 4.4 Global Dydrogesterone Drug Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Dydrogesterone Drug Sales Value by Region 5.1.1 Global Dydrogesterone Drug Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Dydrogesterone Drug Sales Value by Region (2020-2025) 5.1.3 Global Dydrogesterone Drug Sales Value by Region (2026-2031) 5.1.4 Global Dydrogesterone Drug Sales Value by Region (%), (2020-2031) 5.2 Global Dydrogesterone Drug Sales Volume by Region 5.2.1 Global Dydrogesterone Drug Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Dydrogesterone Drug Sales Volume by Region (2020-2025) 5.2.3 Global Dydrogesterone Drug Sales Volume by Region (2026-2031) 5.2.4 Global Dydrogesterone Drug Sales Volume by Region (%), (2020-2031) 5.3 Global Dydrogesterone Drug Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Dydrogesterone Drug Sales Value, 2020-2031 5.4.2 North America Dydrogesterone Drug Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Dydrogesterone Drug Sales Value, 2020-2031 5.5.2 Europe Dydrogesterone Drug Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Dydrogesterone Drug Sales Value, 2020-2031 5.6.2 Asia Pacific Dydrogesterone Drug Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Dydrogesterone Drug Sales Value, 2020-2031 5.7.2 South America Dydrogesterone Drug Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Dydrogesterone Drug Sales Value, 2020-2031 5.8.2 Middle East & Africa Dydrogesterone Drug Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Dydrogesterone Drug Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Dydrogesterone Drug Sales Value and Sales Volume 6.2.1 Key Countries/Regions Dydrogesterone Drug Sales Value, 2020-2031 6.2.2 Key Countries/Regions Dydrogesterone Drug Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Dydrogesterone Drug Sales Value, 2020-2031 6.3.2 United States Dydrogesterone Drug Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Dydrogesterone Drug Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Dydrogesterone Drug Sales Value, 2020-2031 6.4.2 Europe Dydrogesterone Drug Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Dydrogesterone Drug Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Dydrogesterone Drug Sales Value, 2020-2031 6.5.2 China Dydrogesterone Drug Sales Value by Type (%), 2024 VS 2031 6.5.3 China Dydrogesterone Drug Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Dydrogesterone Drug Sales Value, 2020-2031 6.6.2 Japan Dydrogesterone Drug Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Dydrogesterone Drug Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Dydrogesterone Drug Sales Value, 2020-2031 6.7.2 South Korea Dydrogesterone Drug Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Dydrogesterone Drug Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Dydrogesterone Drug Sales Value, 2020-2031 6.8.2 Southeast Asia Dydrogesterone Drug Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Dydrogesterone Drug Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Dydrogesterone Drug Sales Value, 2020-2031 6.9.2 India Dydrogesterone Drug Sales Value by Type (%), 2024 VS 2031 6.9.3 India Dydrogesterone Drug Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Abbott 7.1.1 Abbott Company Information 7.1.2 Abbott Introduction and Business Overview 7.1.3 Abbott Dydrogesterone Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Abbott Dydrogesterone Drug Product Offerings 7.1.5 Abbott Recent Development 7.2 Viatris 7.2.1 Viatris Company Information 7.2.2 Viatris Introduction and Business Overview 7.2.3 Viatris Dydrogesterone Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 Viatris Dydrogesterone Drug Product Offerings 7.2.5 Viatris Recent Development 7.3 Mankind Pharma 7.3.1 Mankind Pharma Company Information 7.3.2 Mankind Pharma Introduction and Business Overview 7.3.3 Mankind Pharma Dydrogesterone Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Mankind Pharma Dydrogesterone Drug Product Offerings 7.3.5 Mankind Pharma Recent Development 7.4 Zydus Cadila Healthcare 7.4.1 Zydus Cadila Healthcare Company Information 7.4.2 Zydus Cadila Healthcare Introduction and Business Overview 7.4.3 Zydus Cadila Healthcare Dydrogesterone Drug Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 Zydus Cadila Healthcare Dydrogesterone Drug Product Offerings 7.4.5 Zydus Cadila Healthcare Recent Development 8 Industry Chain Analysis 8.1 Dydrogesterone Drug Industrial Chain 8.2 Dydrogesterone Drug Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Dydrogesterone Drug Sales Model 8.5.2 Sales Channel 8.5.3 Dydrogesterone Drug Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の 医薬・ヘルスケア分野 での最新刊レポート
本レポートと同じKEY WORD（drug）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
